74 related articles for article (PubMed ID: 12122357)
1. [Non alcoholic steatohepatitis: a multifactorial, frequent, paucysymptomatic liver disease with a fibrotic outcome].
Laroussi N; Mosnier JF; Morel Y; Deugnier Y; Dumas O; Audigier JC
Gastroenterol Clin Biol; 2002 May; 26(5):475-9. PubMed ID: 12122357
[TBL] [Abstract][Full Text] [Related]
2. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
[TBL] [Abstract][Full Text] [Related]
3. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
Bugianesi E; Manzini P; D'Antico S; Vanni E; Longo F; Leone N; Massarenti P; Piga A; Marchesini G; Rizzetto M
Hepatology; 2004 Jan; 39(1):179-87. PubMed ID: 14752836
[TBL] [Abstract][Full Text] [Related]
4. [The prevalence of peripheral iron overload and the presence of HFE gene (H63D) mutation among the Korean patients with nonalcoholic fatty liver disease].
Lee D; Jeong SH; Lee M; Cho YA; Kim JW; Park Y; Hwang JH; Kim NY; Lee DH
Korean J Hepatol; 2007 Jun; 13(2):174-84. PubMed ID: 17585191
[TBL] [Abstract][Full Text] [Related]
5. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.
Fargion S; Mattioli M; Fracanzani AL; Sampietro M; Tavazzi D; Fociani P; Taioli E; Valenti L; Fiorelli G
Am J Gastroenterol; 2001 Aug; 96(8):2448-55. PubMed ID: 11513189
[TBL] [Abstract][Full Text] [Related]
6. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
[TBL] [Abstract][Full Text] [Related]
7. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
[TBL] [Abstract][Full Text] [Related]
8. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000).
Martinelli AL; Filho R; Cruz S; Franco R; Tavella M; Secaf M; Ramalho L; Zucoloto S; Rodrigues S; Zago M
Genet Mol Res; 2005 Mar; 4(1):31-8. PubMed ID: 15841433
[TBL] [Abstract][Full Text] [Related]
9. Role of liver biopsy in the diagnosis of hepatic iron overload in the era of genetic testing.
Nash S; Marconi S; Sikorska K; Naeem R; Nash G
Am J Clin Pathol; 2002 Jul; 118(1):73-81. PubMed ID: 12109859
[TBL] [Abstract][Full Text] [Related]
10. Case report of a patient with non-alcoholic fatty liver disease, moderate iron overload who is homozygous for the S65C mutation in the HFE1 gene.
Bernard PH; Ged C; Faivre E; Legac G; Bioulac-Sage P; Cassaigne A; de Verneuil H
Eur J Med Genet; 2005; 48(2):195-8. PubMed ID: 16053912
[No Abstract] [Full Text] [Related]
11. Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation.
Brandhagen DJ; Alvarez W; Therneau TM; Kruckeberg KE; Thibodeau SN; Ludwig J; Porayko MK
Hepatology; 2000 Feb; 31(2):456-60. PubMed ID: 10655270
[TBL] [Abstract][Full Text] [Related]
12. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
Loria P; Lonardo A; Carulli N
Hepatology; 2004 Jun; 39(6):1748; author reply 1749. PubMed ID: 15185321
[No Abstract] [Full Text] [Related]
13. Iron-overload-related disease in HFE hereditary hemochromatosis.
Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
[TBL] [Abstract][Full Text] [Related]
14. The HFE gene heterozygosis H63D: a cofactor for liver damage in patients with steatohepatitis? Epidemiological and clinical considerations.
Neri S; Pulvirenti D; Signorelli S; Ignaccolo L; Tsami A; Mauceri B; Misseri M; Interlandi D; Cutuli N; Castellino P
Intern Med J; 2008 Apr; 38(4):254-8. PubMed ID: 17916170
[TBL] [Abstract][Full Text] [Related]
15. Iron overload in kidney transplants: prospective analysis of biochemical and genetic markers.
Lorenz M; Kletzmayr J; Huber A; Hörl WH; Sunder-Plassmann G; Födinger M
Kidney Int; 2005 Feb; 67(2):691-7. PubMed ID: 15673318
[TBL] [Abstract][Full Text] [Related]
16. HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma.
Lauret E; Rodríguez M; González S; Linares A; López-Vázquez A; Martínez-Borra J; Rodrigo L; López-Larrea C
Am J Gastroenterol; 2002 Apr; 97(4):1016-21. PubMed ID: 12003382
[TBL] [Abstract][Full Text] [Related]
17. The influence of hemochromatosis mutations on iron overload of thalassemia major.
Longo F; Zecchina G; Sbaiz L; Fischer R; Piga A; Camaschella C
Haematologica; 1999 Sep; 84(9):799-803. PubMed ID: 10477452
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
[TBL] [Abstract][Full Text] [Related]
19. [Iron in the era of molecular biology].
Deugnier Y; Moirand R; Brissot P; David V
Pathol Biol (Paris); 1999 Nov; 47(9):938-44. PubMed ID: 10609274
[TBL] [Abstract][Full Text] [Related]
20. [Hereditary and acquired iron overload].
de Korwin JD
Nephrol Ther; 2006 Nov; 2 Suppl 5():S304-12. PubMed ID: 17373275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
